Henry Schein, Inc. (NASDAQ:HSIC) Receives Consensus Rating of “Moderate Buy” from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has received an average rating of “Moderate Buy” from the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $81.10.

A number of research firms recently commented on HSIC. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. UBS Group cut their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th.

Henry Schein Trading Up 0.1 %

Henry Schein stock opened at $72.17 on Friday. The company has a 50 day moving average price of $74.39 and a 200 day moving average price of $72.45. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market capitalization of $9.00 billion, a price-to-earnings ratio of 29.70, a P/E/G ratio of 2.13 and a beta of 0.91.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the business posted $0.66 EPS. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. Research analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Versant Capital Management Inc raised its holdings in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after purchasing an additional 335 shares in the last quarter. Investment Management Corp VA ADV bought a new position in Henry Schein in the 4th quarter worth $32,000. Venturi Wealth Management LLC raised its holdings in Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC raised its holdings in Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC raised its holdings in Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the period. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.